Cost-effectiveness of warfarin: Trial versus real-world stroke prevention in atrial fibrillationSORENSEN, Sonja V; DEWILDE, Sarah; SINGER, Daniel E et al.The American heart journal. 2009, Vol 157, Num 6, pp 1064-1073, issn 0002-8703, 10 p.Article

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty : A meta-analysisWOLOWACZ, Sorrel E; ROSKELL, Neil S; PLUMB, Jonathan M et al.Thrombosis and haemostasis. 2009, Vol 101, Num 1, pp 77-85, issn 0340-6245, 9 p.Article

How effective are dose-adjusted warfarin and aspirin for the prevention of stroke in patients with chronic atrial fibrillation? : An analysis of the UK General Practice Research DatabaseRIETBROCK, Stephan; PLUMB, Jonathan M; GALLAGHER, Arlene M et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 527-534, issn 0340-6245, 8 p.Article

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillationKANSAL, Anuraag R; SORENSEN, Sonja V; GANI, Ray et al.Heart (London 1996). 2012, Vol 98, Num 7, pp 573-578, issn 1355-6037, 6 p.Article

Treatments for stroke prevention in atrial fibrillation: A network meta-analysis and indirect comparisons versus dabigatran etexilateROSKELL, Neil S; LIP, Gregory Y. H; NOACK, Herbert et al.Thrombosis and haemostasis. 2010, Vol 104, Num 6, pp 1106-1115, issn 0340-6245, 10 p.Article

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacementWOLOWACZ, Sorrel E; ROSKELL, Neil S; PLUMB, Jonathan M et al.Thrombosis and haemostasis. 2010, Vol 103, Num 2, pp 360-371, issn 0340-6245, 12 p.Article

Economic Evaluation of Dabigatran Etexilate for the Prevention of Venous Thromboembolism After Total Knee and Hip Replacement SurgeryWOLOWACZ, Sorrel E; ROSKELL, Neil S; MACIVER, Fiona et al.Clinical therapeutics. 2009, Vol 31, Num 1, pp 194-212, issn 0149-2918, 19 p.Article

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspectiveSORENSEN, Sonja V; KANSAL, Anuraag R; CONNOLLY, Stuart et al.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 908-919, issn 0340-6245, 12 p.Article

Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patientsGALLAGHER, Arlene M; SETAKIS, Efrosini; PLUMB, Jonathan M et al.Thrombosis and haemostasis. 2011, Vol 106, Num 5, pp 968-977, issn 0340-6245, 10 p.Article

Warfarin treatment in patients with atrial fibrillation: Observing outcomes associated with varying levels of INR controlMORGAN, Christopher Ll; MCEWAN, Phil; TUKIENDORF, Andrzej et al.Thrombosis research. 2009, Vol 124, Num 1, pp 37-41, issn 0049-3848, 5 p.Article